Composition for treating inflammation which contains zinc pyrrolidonecarboxylate
A technology of zinc pyrrolidone carboxylate and inhibitors, which is applied in the field of inflammation inhibitors, and can solve the problems of insufficient effect, insoluble in water, insoluble in oily ingredients, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0046] Embodiment 1 The synthesis of synthetic example PCA acid zinc salt and the synthesis of comparative substance
[0047] According to the method disclosed in the patent (Japanese Patent Application Hei 3-168240), the zinc salt of PCA acid was synthesized as follows: by reacting DL-PCA acid and zinc oxide in water at 100°C for 2 hours, and then continuing to stir at room temperature for 5 hours, the precipitated obtained by filtration of the crystals. A commercial item (Tokyo Kasei) was used as a glycine zinc salt as a comparative substance. Zinc lauricate was synthesized as follows. 250 mg (1.25 mmole) of lauric acid was dissolved in 10 mL of ethanol, and a 1% ethanol solution of zinc acetate (Wako Pure Chemical Industries) was separately prepared. 15.1 mL of this 1% zinc acetate (0.69 mmole of zinc acetate, 0.55 equivalent relative to lauric acid) was added to 10 mL of ethanol solution of lauric acid previously prepared, and the resulting precipitate was filtered. The...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More